| Line Item | 2024-02-03 | Y/Y |
|---|---|---|
| Revenue | $5.51B | -7.0% |
| Cost of Revenue | $3.21B | +9.6% |
| Gross Profit | $2.29B | -23.2% |
| R&D Expense | $1.90B | +6.3% |
| SG&A Expense | $834.0M | -1.1% |
| Operating Income | -$567.7M | -338.5% |
| Interest Expense | $211.7M | +24.1% |
| Pre-tax Income | -$758.7M | -991.5% |
| Income Tax | $174.7M |
| Line Item | 2024-02-03 | Y/Y |
|---|---|---|
| Cash & Equivalents | $950.8M | +4.4% |
| Accounts Receivable | $1.12B | -5.9% |
| Inventory | $864.4M | -19.1% |
| Current Assets | $3.06B | -6.7% |
| Total Assets | $21.23B | -5.7% |
| Current Liabilities | $1.81B | -24.0% |
| Long-term Debt | $4.17B | -7.3% |
| Line Item | 2024-02-03 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.37B | +6.3% |
| Capital Expenditures | $336.3M | +63.1% |
| Investing Cash Flow | -$350.5M | -6.7% |
| Financing Cash Flow | -$980.2M | -47.9% |
| Free Cash Flow | $1.03B | -4.5% |
| -29.7% |
| Net Income | -$933.4M | -470.9% |
| EPS (Basic) | -$1.08 | -468.4% |
| EPS (Diluted) | -$1.08 | -468.4% |
| Total Liabilities |
| $6.40B |
| -7.1% |
| Stockholders' Equity | $14.83B | -5.2% |